Current stock page

Financial Data

COGT Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

COGTCogent Biosciences, Inc.

Healthcare / Biotechnology

Low Priority

Above Peers

BearishEdge 7/10
$28.56−$0.58 (−1.99%)

Latest quote

  • Momentum
    45
  • Value
    —
  • Quality
    40
  • Risk resilience
    51
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
0
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated —.

Income statement
0 periods

No quarterly history is available for this statement.

Cash flow statement
0 periods

No quarterly history is available for this statement.

Balance sheet
0 periods

No quarterly history is available for this statement.

Key financial metrics
0 periods

No quarterly history is available for this statement.

Financial ratios
0 periods

No quarterly history is available for this statement.

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-12.31x
Pb9.58x
Gross Margin0.00%
Operating Margin0.00%
ROE-71.13%
ROIC-55.60%
Debt To Equity0.47
FCF Yield-6.56%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$28.56
Volume1.15M
RSI (14)40.78
MACD-0.43
MACD signal-0.25
MACD histogram-0.18
ADX (14)17.55
SMA (50)$31.39
SMA (200)$35.30
ATR (14)$1.66
Historical volatility (annualized)62.12%
Volume (20-day average)2.1M

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score51/100
Beta1.38
Annual volatility45.96%
Max Drawdown-34.43%
Sharpe Ratio-0.23
VaR (95%, 1-day)-4.53%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

COGT Financial Data FAQ

What is Cogent Biosciences, Inc.'s revenue?

Cogent Biosciences, Inc.'s revenue is one of the core financial data points for COGT. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Cogent Biosciences, Inc.'s revenue growing?

Revenue growth shows whether Cogent Biosciences, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is COGT's EPS?

COGT's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Cogent Biosciences, Inc.'s net income?

Cogent Biosciences, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Cogent Biosciences, Inc. generate?

Free cash flow shows how much cash Cogent Biosciences, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Cogent Biosciences, Inc. have?

Cash and debt help frame COGT's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.